A closely watched study that aimed to remove the financial incentive for doctors to prescribe expensive cancer drugs delivered a contradictory result with lower overall treatment spending but higher chemotherapy medication costs The results of the study which involved UnitedHealth Group Incs insurance arm and five oncology practices raise questions about the most effective way to trim the rapidly growing tab for cancer care The US spent more on cancer drugs last year  billion up  in five yearsthan any other
  